PROTEINURIA
Clinical trials for PROTEINURIA explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIA trials appear
Sign up with your email to follow new studies for PROTEINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for cancer patients: drug may shield kidneys from treatment side effect
Disease control Not yet recruitingThis early study tests if the drug sparsentan can reduce high levels of protein in the urine (a sign of kidney damage) in 20 cancer patients receiving VEGF inhibitor therapy. The goal is to see if sparsentan can help protect kidney function without interrupting cancer treatment. …
Matched conditions: PROTEINURIA
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Herbal hope: huaier granule tested for proteinuria in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether adding Huaier Granule to standard care can better treat proteinuria (excess protein in urine) in breast cancer patients who developed this side effect from immunotherapy or anti-angiogenic drugs. About 120 women aged 18-75 will be randomly assigned to rec…
Matched conditions: PROTEINURIA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Symptom relief
Last updated May 17, 2026 03:09 UTC
-
Herbal granules aim to ease kidney side effect of lung cancer drugs
Symptom relief Not yet recruitingThis study tests whether Huaier Granules, a traditional Chinese medicine, can reduce protein in the urine (proteinuria) caused by two common lung cancer drugs, Bevacizumab and Anlotinib. About 40 adults with lung cancer and mild to moderate proteinuria will take the granules or s…
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: Fudan University • Aim: Symptom relief
Last updated May 11, 2026 20:49 UTC
-
New alert system aims to speed up kidney care for At-Risk patients
Knowledge-focused Not yet recruitingThis study looks at whether an alert in the electronic health record can prompt primary care doctors to refer patients with blood and protein in their urine to a kidney specialist. About 1,200 adults with these high-risk signs will be included. The goal is to improve early detect…
Matched conditions: PROTEINURIA
Phase: NA • Sponsor: Geisinger Clinic • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
New study to analyze Real-World use of iptacopan for rare kidney disease
Knowledge-focused Not yet recruitingThis study looks at medical records of 83 adults with C3 glomerulopathy (a rare kidney disease) who are taking the drug iptacopan. Researchers will describe patients' health history, lab results, and how their disease changes over a year. The goal is to learn more about the types…
Matched conditions: PROTEINURIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC